Company Egalet Corp Nasdaq
Equities
US28226B1044
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Todd Smith
CEO | Chief Executive Officer | 55 | 22/10/19 |
Daniel Peisert
DFI | Director of Finance/CFO | 49 | 19/05/20 |
Investor Relations Contact | - | 31/01/15 | |
Comptroller/Controller/Auditor | 49 | 31/08/13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Todd Smith
CEO | Chief Executive Officer | 55 | 22/10/19 |
Daniel Peisert
DFI | Director of Finance/CFO | 49 | 19/05/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,611,957 | 8,680,163 ( 90.31 %) | 0 | 90.31 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |